期刊文献+

震颤与非震颤帕金森病患者11C-CFT和18F-FDG PET/CT显像的代谢特点 被引量:6

Metabolic patterns of 11C-CFT and 18F-FDG PET/CT imaging in tremor and non-tremor Parkinson′s disease
原文传递
导出
摘要 目的通过11C-2β-甲氧甲酰-3β-(4-氟苯基)托烷(CFT)和18F-脱氧葡萄糖(FDG) PET/CT脑显像研究震颤与非震颤帕金森病(PD)患者的代谢特点。方法纳入2018年3月至2019年3月的PD患者28例[震颤组19例:男14例、女5例,年龄(59.9±11.4)岁;非震颤组9例:男3例、女6例,年龄(62.6±9.0)岁]。采用感兴趣区(ROI)技术进行计算,比较2组患者尾状核、前壳核和后壳核11C-CFT摄取值及各脑区18F-FDG的摄取值。采用两样本t检验或Mann-Whitney u检验分析数据。结果震颤组PD患者的尾状核11C-CFT摄取值明显高于非震颤组(3.03±0.51与2.60±0.62;t=2.687, P<0.05),而非震颤组患者丘脑18F-FDG的摄取值明显高于震颤组(1.14±0.05与1.10±0.03;t=3.449, P<0.01)。以改良Hoehn-Yahr分级判定病情严重程度,震颤组患者在疾病进展期(分级≥2.5级)壳核和小脑葡萄糖代谢均较非震颤组进展期增高(1.27±0.04与1.21±0.05,0.94±0.04与0.86±0.08;t值:2.695和2.492,均P<0.05),震颤组进展期运动前区代谢较早期减低(1.07±0.02与1.10±0.03;t=2.053,P<0.05)。结论11C-CFT和18F-FDG PET/CT显像能较好地反映震颤与非震颤PD患者的不同代谢特征,有助于2种疾病亚型的临床诊疗和鉴别诊断。 Objective To investigate the metabolic patterns of 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (CFT) and 18F-fluorodeoxyglucose (FDG) PET/CT imaging in patients with tremor and non-tremor Parkinson′s disease (PD). Methods From March 2018 to March 2019, 28 PD patients (19 tremor patients: 14 males and 5 females, age:(59.9±11.4) years;9 non-tremor patients: 3 males and 6 females, age:(62.6±9.0) years) were enrolled. For the two groups, the 11C-CFT uptake values in caudate nucleus, anterior putamen and posterior putamen as well as 18F-FDG uptake values in all brain regions were calculated by regions of interest (ROI) method. Two-sample t test or Mann-Whitney u test were used to analyze the data. Results Caudate nucleus 11C-CFT uptake in PD patients with tremor was higher than that without tremor (3.03±0.51 vs 2.60±0.62;t=2.687, P<0.05). Yet thalamus glucose uptake of non-tremor PD patients showed more active than tremor patients (1.14±0.05 vs 1.10±0.03;t=3.449, P<0.01). Sorted by modified Hoehn-Yahr stage, tremor patients in advanced stage (stage≥2.5) were characterized by glucose uptake increase in the putamen and cerebellum compared with non-tremor advanced group (1.27±0.04 vs 1.21±0.05, 0.94±0.04 vs 0.86±0.08;t values: 2.695 and 2.492, both P<0.05). Metabolic decrease in the premotor areas was observed in tremor patients in advanced stage compared with early stage (1.07±0.02 vs 1.10±0.03;t=2.053, P<0.05). Conclusion 11C-CFT and 18F-FDG PET/CT imaging can indicate different metabolic patterns between tremor and non-tremor PD, thus providing information for clinical practice and differential diagnosis.
作者 辛玫 张晨鹏 王成 万良荣 王智樱 管阳太 刘建军 黄钢 Xin Mei;Zhang Chenpeng;Wang Cheng;Wan Liangrong;Wang Zhiying;Guan Yangtai;Liu Jianjun;Huang Gang(Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China;Department of Neurology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China;Shanghai University of Medicine and Health Sciences, Shanghai 201318, China)
出处 《中华核医学与分子影像杂志》 CAS 北大核心 2019年第6期344-348,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 上海申康医院发展中心临床创新三年行动计划(16CR2020A) 国家自然科学基金(81701725) 上海市"医苑新星"青年医学人才培养资助计划(沪卫人事[2012]105号).
关键词 帕金森病 震颤 正电子发射断层显像术 体层摄影术 X线计算机 托烷类 脱氧葡萄糖 Parkinson disease Tremor Positron-emission tomography Tomography, X-ray computed Tropanes Deoxyglucose
  • 相关文献

参考文献4

二级参考文献76

  • 1张锦明,田嘉禾,王武尚,刘伯里.单管法自动化合成^(11)C-碘代甲烷[J].中华核医学杂志,2004,24(4):243-244. 被引量:24
  • 2Dannals RF, Neumeger JL, Milius RA, et al. Synthesis of radiotracer for studing dopamine uptake site in vivo using PET: 2-β-carbomethoxy-3-β(4-fluorophenyl)-(N-^11C-methyl) tropane (^11C-CFT). J Labelled Comp Radiopharm,1993, 33: 147-152.
  • 3Melega W, Lacan G, Desalles A, et al. Long-term methamphetamine-induced decreases of ^11C-WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey. Synapse, 2000, 35: 243-249.
  • 4Jewett DM. A simple synthesis of ^11C-methyl-triflate. Appl Rad Isotope,1992, 43: 1383-1385.
  • 5Rinne JO, Laihinen A, Nagem K, et al. PET examination of the monoamine transporter with ^11C-β-CIT and ^11C-β-CFT in early Parkinson' s disease. Synapse, 1995, 21: 97-103.
  • 6Neumeger JL, Tamagnan G, Wang S, et al. N-substituted analogs of 2-β-carbomethoxy-3-β-(4'-iodophenyl) tropane (β-CIT) with selective affinity to dopamine or serotonin transports in rat forebrain. J Med Chem, 1996,39: 543-548.
  • 7Laakso A, Bergman J, Haaparanta M, et al. ^18F-CFT (^18F-WIN 35,428), a radioligand to study the dopamine transporter with PET: characterization in human subjects. Synapse, 1998, 28: 244-250.
  • 8Ouchi Y, Kanno T, Okade H, et al. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson' s disease: a double-tracer positron emission tomography study. Ann Neurol, 1999, 46: 723-731.
  • 9Stoessl A J, Brooks DJ, Eidelberg D. Milestones in neumimaging. Mov Disord, 2011, 26: 868-978.
  • 10Hughes A J, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson' s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 1992, 55: 181-184.

共引文献51

同被引文献43

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部